1. Home
  2. ALKS vs BGC Comparison

ALKS vs BGC Comparison

Compare ALKS & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • BGC
  • Stock Information
  • Founded
  • ALKS 1987
  • BGC 1945
  • Country
  • ALKS Ireland
  • BGC United States
  • Employees
  • ALKS N/A
  • BGC N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • BGC Investment Bankers/Brokers/Service
  • Sector
  • ALKS Health Care
  • BGC Finance
  • Exchange
  • ALKS Nasdaq
  • BGC Nasdaq
  • Market Cap
  • ALKS 4.5B
  • BGC 4.4B
  • IPO Year
  • ALKS 1991
  • BGC 1999
  • Fundamental
  • Price
  • ALKS $30.13
  • BGC $9.17
  • Analyst Decision
  • ALKS Buy
  • BGC Strong Buy
  • Analyst Count
  • ALKS 12
  • BGC 2
  • Target Price
  • ALKS $38.33
  • BGC $14.50
  • AVG Volume (30 Days)
  • ALKS 2.0M
  • BGC 2.8M
  • Earning Date
  • ALKS 05-01-2025
  • BGC 05-07-2025
  • Dividend Yield
  • ALKS N/A
  • BGC 0.87%
  • EPS Growth
  • ALKS N/A
  • BGC 128.63
  • EPS
  • ALKS 2.09
  • BGC 0.27
  • Revenue
  • ALKS $1,513,770,000.00
  • BGC $2,252,851,000.00
  • Revenue This Year
  • ALKS N/A
  • BGC $20.50
  • Revenue Next Year
  • ALKS $4.09
  • BGC $10.20
  • P/E Ratio
  • ALKS $14.30
  • BGC $34.55
  • Revenue Growth
  • ALKS N/A
  • BGC 13.24
  • 52 Week Low
  • ALKS $22.90
  • BGC $7.24
  • 52 Week High
  • ALKS $36.45
  • BGC $11.79
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 51.87
  • BGC 54.18
  • Support Level
  • ALKS $29.78
  • BGC $9.07
  • Resistance Level
  • ALKS $31.99
  • BGC $9.84
  • Average True Range (ATR)
  • ALKS 1.04
  • BGC 0.31
  • MACD
  • ALKS 0.42
  • BGC 0.06
  • Stochastic Oscillator
  • ALKS 64.09
  • BGC 54.73

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Share on Social Networks: